CClinicalTrials.gg
CompletedNCT03785600SPTBIUpdated Sep 22, 2025Results posted

Improving Sleep in Veterans With TBI

An interventional study of Morning Bright Light Therapy and Negative Ion Generator in Traumatic Brain Injury, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-09-22.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Traumatic brain injury (TBI) is a major cause of disability in the Veteran population, often resulting in chronic pain and sleep disturbances, among other issues. Extensive rehabilitative efforts are usually required and often prevent return to the workforce and community. Disturbed sleep and excessive daytime sleepiness are among the most pervasive and enduring problems after TBI, which the investigators hypothesize is a significant contributor to these functional impairments and an impediment toward rehabilitation. Thus, this research aims to enhance sleep quality as a means to reduce pain and improve quality of life and functional outcome measures in Veterans with TBI. The investigators predict that the proposed intervention, morning bright light therapy, if found effective, will be cost-effective, rapidly deployable, and highly accepted by Veterans with TBI.

Read the detailed description

Each year \~2.5 million people sustain a traumatic brain injury (TBI). Also a prominent general public health issue, TBI is particularly prevalent in Veterans, with 60-80% reporting a history of TBI. Over 80% of all TBI are categorized as mild TBI (mTBI), which is associated with a myriad of short- and long-term complications. Two of the principal complicating factors associated with mTBI are sleep-wake disturbances (e.g., insomnia, excessive daytime sleepiness, and circadian rhythm sleep disorders) and chronic pain, including headache and diffuse/global pain. Sleep-wake disturbances and chronic pain have an independent prevalence of \~70%, individually impair quality of life, impede effective rehabilitative therapies, and have staggering functional and economic impacts.

Furthermore, there is a strong bidirectional relationship between sleep-wake disturbances and pain such that impaired sleep exacerbates pain, which leads to greater impairments in sleep and worse pain. This vicious cycle between sleep disturbances and pain, which is a particularly prevalent and detrimental condition in Veterans with chronic mTBI, represents a central challenge precluding effective treatment and ultimately, improving Veteran quality of life. Although there are pharmacological and non-pharmacological therapies for chronic pain, the presence of TBI significantly complicates the effectiveness of these treatment options, and have significant adverse effects (e.g., long-term prescription opioid dependence, misuse, or overdose). The investigators believe there is profound potential to intervene at the sleep level, and, by improving sleep quality, enable Veterans with chronic mTBI to better manage their pain and end this vicious cycle.

This proposal aims to apply a sleep intervention to improve chronic pain in Veterans with mTBI. The investigators propose to use morning bright light therapy (MBLT), a readily deployable, cost-effective, non-pharmacologic, and home-based sleep intervention, to improve sleep-wake disturbances and therefore ameliorate chronic pain and improve quality of life in Veterans with chronic mTBI. Outcomes will be assessed pre- and post-intervention, and at a 3-month follow-up time point. The central hypothesis is that MBLT will improve sleep quality and ameliorate pain, resulting in improved quality of life in Veterans with chronic mTBI.

02

Conditions studied

  • Traumatic Brain Injury

Keywords

  • traumatic brain injury
  • sleep-wake disturbances
  • Veterans
  • chronic pain
03

In context

Brain Injuries, Traumatic

1,775 studies on the registry are indexed under Brain Injuries, Traumatic; 448 are open to participants now.

This study's enrollment of 77 is above the median of 56 across 1,133 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Veteran
  • Medical record-confirmed diagnosis of mTBI
  • Current self-reported sleep-wake disturbances

    • defined by clinically abnormal Insomnia Severity Index and/or Functional Outcomes of Sleep scores
  • Moderate to severe pain

    • defined as a score of 4 on an 11-point scale94) persisting for longer than 6 months
  • English speaking with phone access

Exclusion Criteria:

Exclusion Criteria:

  • Decisional impairment and/or dementia
  • Current usage of a lightbox or negative ion generator
  • Shift work
  • History of macular degeneration and/or bipolar disorder
  • Evidence for suicidal ideation
  • Cancer diagnosis within the past 6 months
  • Surgery within the past 6-12 months
  • Substance abuse within the past 6-12 months
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
77 participants (actual)

Study arms

  • Experimental
    Morning Bright Light Therapy

    Morning bright light: Sitting in front of a lightbox for 60 minutes every morning within 90 minutes of waking up.

    Device: Morning Bright Light Therapy

  • Sham comparator
    Negative Ion Generator

    Negative ion generator: Sitting in front of a modified negative ion generator for 60 min every morning within 90 minutes of waking up.

    Device: Negative Ion Generator

Interventions

  • DeviceMorning Bright Light Therapy

    Morning bright light: Sitting in front of a lightbox for 60 minutes every morning within 90 minutes of waking up.

    Also known as: Lightbox, light therapy

  • DeviceNegative Ion Generator

    Negative ion generator: Sitting in front of a modified negative ion generator for 60 min every morning within 90 minutes of waking up.

06

What researchers measure

Primary outcomes

  1. Change in Self-reported Pain

    NIH Patient Reported Outcomes Measurement Information System (PROMIS) pain interference short-form 4a. 4 questions; each question is a 1-5 Likert scale, total score range is 4-20. Higher scores represent greater pain interference. \*all are reported as total score, no subscale scores present.

    Time frame: Pre- and post-4 weeks of Morning Bright Light Therapy (MBLT) or sham treatment.

07

Results

Posted Sep 22, 2025

Participant flow

Participant flow — Overall Study
MilestoneMorning Bright Light TherapyNegative Ion Generator
Started5324
Completed4420
Not completed94

Outcome measures

PrimaryChange in Self-reported Pain

NIH Patient Reported Outcomes Measurement Information System (PROMIS) pain interference short-form 4a. 4 questions; each question is a 1-5 Likert scale, total score range is 4-20. Higher scores represent greater pain interference. \*all are reported as total score, no subscale scores present.

Time frame:
Pre- and post-4 weeks of Morning Bright Light Therapy (MBLT) or sham treatment.
Reported as:
Mean · Score on Pain Interference
Change in Self-reported Pain
Score on Pain InterferenceMorning Bright Light TherapyNegative Ion Generator
Mean Pre-Intervention Pain Interference9.8 ± 4.810.2 ± 4.7
Mean Post-Intervention Pain Interference9.3 ± 4.810.0 ± 5.0
Statistical analysis
  • Morning Bright Light Therapy vs Negative Ion Generator · t-test, 2 sided · p = <0.02 (a priori threshold is \<0.05.)

Adverse events

Collected over Adverse event data was collected started immediately after consent and ended after participants completed all study activities (up to 20 weeks).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Morning Bright Light Therapy0/53 (0%)0/53 (0%)0/53 (0%)
Negative Ion Generator0/24 (0%)0/24 (0%)1/24 (4.2%)
Most frequent other events
Most frequent other events
EventMorning Bright Light TherapyNegative Ion Generator
Non-SeriousPsychiatric disorders0/531/24

Baseline characteristics

Age, Continuous
Age, Continuous(years)Morning Bright Light TherapyNegative Ion GeneratorTotal
Mean53.6 ± 13.451.8 ± 14.353.1 ± 13.6
Sex: Female, Male
Sex: Female, Male(Participants)Morning Bright Light TherapyNegative Ion GeneratorTotal
Female10414
Male341650
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Morning Bright Light TherapyNegative Ion GeneratorTotal
Hispanic or Latino707
Not Hispanic or Latino371956
Unknown or Not Reported011
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Morning Bright Light TherapyNegative Ion GeneratorTotal
American Indian or Alaska Native314
Asian011
Native Hawaiian or Other Pacific Islander000
Black or African American101
White381654
More than one race213
Unknown or Not Reported011
Years of Education
Years of Education(years)Morning Bright Light TherapyNegative Ion GeneratorTotal
Mean16.5 ± 1.815.6 ± 1.916.2 ± 1.9
08

Study locations

1 site
  • VA Portland Health Care System, Portland, OR
    Portland, Oregon 97207-2964, United States
09

References and documents

Publications

  • Elliott JE, Brewer JS, Keil AT, Ligman BR, Bryant-Ekstrand MD, McBride AA, Powers K, Sicard SJ, Twamley EW, O'Neil ME, Hildebrand AD, Nguyen T, Morasco BJ, Gill JM, Dengler BA, Lim MM. Feasibility and acceptability for LION, a fully remote, randomized clinical trial within the VA for light therapy to improve sleep in Veterans with and without TBI: An MTBI2 sponsored protocol. PLoS One. 2025 Jan 7;20(1):e0305305. doi: 10.1371/journal.pone.0305305. eCollection 2025. PubMed 39775195 ↗

Study documents

  • Study protocol · Nov 15, 2023
  • Informed consent form · Nov 15, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03785600
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Dec 24, 2018
Start date
Nov 1, 2019
Primary completion
Jul 31, 2024
Completion
Sep 30, 2024
Results posted
Sep 22, 2025
Last update
Sep 22, 2025

Study contacts

Jonathan E Elliott, PhD
principal investigator · VA Portland Health Care System, Portland, OR

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion